Navigation Links
Nucletron, an Elekta Company, Receives U.S. FDA 510(k) Clearance for Esteya Electronic Brachytherapy System for Treating Skin Cancer
Date:10/2/2013

ATLANTA, Oct. 2, 2013 /PRNewswire/ -- Esteya®, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option.

Esteya is a new approach for high precision skin cancer treatment. The system relies on a small, high dose rate (HDR) to apply radiation directly to the cancerous site. This direct delivery enables Esteya to focus more therapeutic radiation on the disease target and to minimize radiation to surrounding tissues and organs. Electronic brachytherapy is well-suited for treating skin lesions, such as basal cell or squamous cell carcinoma, achieving a greater than 95 percent cure rate for this technique.

"The interest in Esteya among radiation oncologists during the American Society for Radiation Oncology annual meeting last week in Atlanta was encouraging," John Lapre, EVP Brachytherapy at Elekta commented. "They appreciated the efficient workflow, easy patient set-up, and the short treatment delivery time. They also cited the accessibility of Esteya – due to its compact design and reduced shielding requirements – allowing treatment to occur virtually anywhere patients are seen within the clinic."

The first installations of Esteya in the United States are scheduled to occur in the next few months.

To learn more about Esteya, visit Esteya.com.

Availability of Esteya in target markets is dependent on regulatory admissions and approvals.

For further information, please contact: 
Johan Andersson, Director, Investor Relations, Elekta AB 
Tel: +46 702 1
'/>"/>

SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nucletron, an Elekta company, to Debut New Flexitron Brachytherapy Afterloading Platform at 2013 American Brachytherapy Society Meeting
2. Elekta Announces Monaco 5.0 -- Comprehensive Radiation Treatment Planning Capabilities Brought Together in One System
3. New Elekta Radiation Therapy Technology Takes Weeks Off of Lung Cancer Treatments
4. Switzerlands Hopital Riviera Improves Confidence in Patient Treatment with Elektas Identify Solution
5. Elekta to Spotlight Versa HD System at 2013 ASTRO Annual Meeting
6. Elekta Introduces Groundbreaking Image Guidance Capabilities Integrated with Versa HD Cancer Treatment System
7. Johns Hopkins Kimmel Cancer Center Acquires Elekta Versa HD System
8. Elektas Leksell Gamma Knife Perfexion and Elekta Infinity Place First and Second in 2013 KLAS Radiation Therapy Report
9. Elekta to Exhibit New Versa HD Radiotherapy System at Annual Radiation Physics Conference
10. Odense Universitetshospital tilfører kræftpatienters stereotaktiske strålebehandling næsten tre gange hurtigere med Elektas Versa HD-system
11. Elekta Receives CE Marking for Clarity 4D Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from ... China,s orthopedic instrument industry has seen ... rising from 3.28 billion yuan in 2006 to 9.85 ...
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ( ... "Dental Consumables Market - Global Industry Analysis, Size, Share, ... to their offering. (Logo: ... which are used on patients in order to treat ...
(Date:1/15/2014)... WASHINGTON , Jan. 15, 2014 AARP Foundation today ... support older adults suffering from the severe cold weather that ... are committed to helping those in need; so to support ... dollar-for-dollar contributions up to $250,000, which could mean up to ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... April 24 Novagali Pharma, an emerging,ophthalmic pharmaceutical ... first patient in a Phase I clinical trial ... technology platform,containing a corticosteroid prodrug for the treatment ... enrol a total of 15 patients, is,designed to ...
... CAMBRIDGE, Massachusetts, April 24, Shire plc (LSE: ... announces the acquisition of,arylsulfatase -A (ASA) an ... trials for Metachromatic Leukodystrophy (MLD) from the ... a serious, life-limiting disease in which patients ...
Cached Medicine Technology:Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema 2Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy 2Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy 3
(Date:4/17/2014)... chronic inflammation in benign prostate tissue was associated ... association was found even in those with low ... published in Cancer Epidemiology, Biomarkers & Prevention ... Cancer Research. , An analysis of prostate tissue ... arm of the Prostate Cancer Prevention Trial (PCPT) ...
(Date:4/17/2014)... popular vaccine brands for children may not be the ... cost factors when choosing vaccines, driving the market toward ... a new study by University of Illinois researchers. , ... by numerous factors," says Sheldon H. Jacobson, a co-author ... and of mathematics at the U. of I. "In ...
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... April 17, 2014U.S. military personnel who served in ... concussive traumatic brain injury (TBI) were compared to ... other medical reasons. Differences in measures of overall ... months after injury are reported in an article ... journal from Mary Ann Liebert, Inc., publishers. The ...
(Date:4/17/2014)... about one in five infants in the United States ... first several months after birth. Research into probiotic use ... the April 1, 2014 issue of the British ... study, "Probiotics and Infant Colic," concluding that the use ... colic did not reduce crying or fussing in ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... SXC Health Solutions, Inc.,("SXC" or the "Company") (NASDAQ: ... of,pharmacy benefits management services, announces that Mark Thierer,President ... Vice President,and Chief Financial Officer, will present at ... Grand Hyatt in New York City. SXC,s presentation,will ...
... Bermuda, Jan. 28 Warner Chilcott,Limited (Nasdaq: WCRX ) ... Total revenues for 2008 are expected to be in the ... driven by LOESTRIN 24 FE, DORYX,FEMCON FE, and TACLONEX. Gross ... be in the range of 80% to 81% in 2008., ...
... While many of today,s seniors are,retiring into what ... of life,they want to stay connected to the "real ... to trustworthy information and resources. In,addition, these adults are ... referrals for home repairs to coordinating personal,transportation and even ...
... NTY ), (http://www.NBTY.com ), a leading global manufacturer ... fiscal first quarter ended,December 31, 2007., For the ... were,$511 million compared to $506 million for the fiscal ... million or 1%., Net income for the fiscal ...
... Demo 08 -- Today, at DEMO 08,Acesis Inc. ... a,revolutionary on-demand electronic health record software solution. Acesis,Point-of-Care ... professionals by providing a secure, intuitive data capture,system ... "Acesis Point-of-Care is a striking example of ...
... 10 a.m. EST, January 28, 2008, WALTHAM, Mass., ... and Matria Healthcare, Inc. (Nasdaq: MATR ) today,announced ... to,which Inverness will acquire all outstanding shares of common ... cash plus $32.50 in,convertible preferred stock of Inverness (convertible ...
Cached Medicine News:Health News:SXC Health Solutions to present at the 2008 UBS Global Healthcare Services Conference 2Health News:Warner Chilcott Announces 2008 Financial Guidance 2Health News:Warner Chilcott Announces 2008 Financial Guidance 3Health News:Warner Chilcott Announces 2008 Financial Guidance 4Health News:Warner Chilcott Announces 2008 Financial Guidance 5Health News:Senior Citizens Bureau Empowers Today's Seniors: National Non-profit Serves as Community Resource for Seniors, Their Children, Caregivers and Even Advocates 2Health News:Senior Citizens Bureau Empowers Today's Seniors: National Non-profit Serves as Community Resource for Seniors, Their Children, Caregivers and Even Advocates 3Health News:NBTY Reports First Quarter Results 2Health News:NBTY Reports First Quarter Results 3Health News:NBTY Reports First Quarter Results 4Health News:NBTY Reports First Quarter Results 5Health News:NBTY Reports First Quarter Results 6Health News:NBTY Reports First Quarter Results 7Health News:NBTY Reports First Quarter Results 8Health News:NBTY Reports First Quarter Results 9Health News:NBTY Reports First Quarter Results 10Health News:NBTY Reports First Quarter Results 11Health News:NBTY Reports First Quarter Results 12Health News:NBTY Reports First Quarter Results 13Health News:NBTY Reports First Quarter Results 14Health News:Acesis Point-of-Care, The Physician's Ultimate Replacement for Pen and Paper, Unveiled at DEMO 08 2Health News:Acesis Point-of-Care, The Physician's Ultimate Replacement for Pen and Paper, Unveiled at DEMO 08 3Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 2Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 3Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 4Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 5Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 6
... higher magnification and increased stereopsis, the Central ... visualization to the equatorial regions. The Central ... and in membrane peeling in proliferative vitreoretinopathy ... Lenses The ACS Vitrectomy Lenses from Volk ...
... the high resolution, high magnification and field ... simple two part design separates for easy ... Simply autoclave, add saline or water to ... use. (ACS) AutoClave Sterilizable Lenses The ACS ...
... These patented ACS lenses offer the ... view as the original clariVits. The simple ... while maintaining its integrity during surgery. Simply ... contact element, then lock together for use. ...
... over a wide field ... entire retina, detailed retinal ... tears, diagnosis and treatment ... the vitreous cavity is ...
Medicine Products: